Roles & Responsibilities
• Develop and maintain pharmaceutical forecasting models across multiple therapeutic areas
• Support portfolio strategy and valuation decisions in collaboration with BD Analytics HOCT team
• Apply statistical forecasting, time-series analysis, and predictive modeling techniques
• Perform scenario analysis related to pricing, market access, and regulatory outcomes
• Analyze large datasets including sales forecasts, epidemiology, and competitive intelligence
• Build advanced Excel-based forecasting and financial models, including dashboards
• Prepare insight-driven reports and PowerPoint presentations for senior leadership
• Collaborate with cross-functional and IT teams to automate data collection and reporting
• Monitor market trends, competitor activity, and pipeline developments
Qualification
• Bachelor’s or Master’s degree in Biology, Biotechnology, Finance, Economics, Business, or related field
• MBA preferred but not mandatory
Experience
• 1–3 years of experience in pharmaceutical forecasting, portfolio analytics, or commercial analytics
• Prior exposure to Oncology, Hematology, or Cell Therapy is an added advantage
Skills
• Strong proficiency in Advanced Excel and VBA
• Experience handling pharma datasets (sales, epidemiology, competitive intelligence)
• Knowledge of forecasting methodologies and analytical modeling
• Exposure to BI tools, forecasting software, or Python is a plus
• Strong analytical, problem-solving, and critical-thinking skills
• Excellent communication and stakeholder management abilities
• Ability to work independently and collaborate across teams
About the Organisation
Bristol Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. With a strong presence in Oncology, Hematology, and Cell Therapy, BMS leverages advanced analytics and data-driven decision-making to shape portfolio strategy and drive impactful business outcomes worldwide.
Unlock refined AI insights.